United State

English

STAT News

STAT News

About: STAT delivers trusted and authoritative journalism about health, medicine, and the life sciences. Millions of new readers turned to us as we sounded the alarm early on about the Covid-19 pandemic. Our journalists go deep in tough-minded coverage of the business of making medicines, health tech, science, and public health.
Contact Us: Email: first.opinion@statnews.com
Pharmacies nervous about Medicare Drug Price Negotiation Program

Pharmacies nervous about Medicare Drug Price Negotiation Program

Weight loss drugs don’t mean we can abandon obesity prevention

Weight loss drugs don’t mean we can abandon obesity prevention

Trump administration embraces Medicare drug negotiations

Trump administration embraces Medicare drug negotiations

Patients are already using AI. How can the health care system help?

Patients are already using AI. How can the health care system help?

Sarepta Duchenne drug, Otsuka, Prasad, Medicare: The Readout

Sarepta Duchenne drug, Otsuka, Prasad, Medicare: The Readout

New CDC leader, hep B vaccine, beagles: Morning Rounds

New CDC leader, hep B vaccine, beagles: Morning Rounds

We’re reading about Medicare drug prices, FDA voucher program

We’re reading about Medicare drug prices, FDA voucher program

Tatiana Schlossberg's diagnosis shows two Kennedys, two paths

Tatiana Schlossberg's diagnosis shows two Kennedys, two paths

Vaccine Integrity Project undertakes hepatitis B review

Vaccine Integrity Project undertakes hepatitis B review

Nursing is a profession, period

Nursing is a profession, period

Why so many beagles are used in lab research

Why so many beagles are used in lab research

Medicare releases new list of negotiated drug prices

Medicare releases new list of negotiated drug prices

FDA approves Otsuka therapy to treat a chronic, autoimmune kidney disease

FDA approves Otsuka therapy to treat a chronic, autoimmune kidney disease

Health insurers trying to avoid costly Medicare enrollees draw scrutiny

Health insurers trying to avoid costly Medicare enrollees draw scrutiny

STAT Health Tech: Therapy chatbot study lands with a thud

STAT Health Tech: Therapy chatbot study lands with a thud

We’re reading about Novo diabetes drug, Novartis SMA therapy

We’re reading about Novo diabetes drug, Novartis SMA therapy

My chronic disease isn’t a ‘journey,’ it’s a bad trip

My chronic disease isn’t a ‘journey,’ it’s a bad trip

Why lung cancer screening so often fails

Why lung cancer screening so often fails

Federal biotech commission urges an overhaul of research funding

Federal biotech commission urges an overhaul of research funding

Trump health care plan: Momentum builds for ACA subsidy extension

Trump health care plan: Momentum builds for ACA subsidy extension

Health Care Inc.: Picking a health insurance plan

Health Care Inc.: Picking a health insurance plan

Medicare backs off plan for quicker clawback of $7.8 billion from hospitals

Medicare backs off plan for quicker clawback of $7.8 billion from hospitals

GLP

GLP

J&J’s novel Alzheimer’s drug fails in key trial, dimming hopes for a hot target

J&J’s novel Alzheimer’s drug fails in key trial, dimming hopes for a hot target

We’re reading about Novo Alzheimer’s trials, Bayer stroke results

We’re reading about Novo Alzheimer’s trials, Bayer stroke results

FDA, CDC, neurodiversity, Healthy Start: Morning Rounds

FDA, CDC, neurodiversity, Healthy Start: Morning Rounds

Novo Nordisk's semaglutide fails to slow Alzheimer's progression

Novo Nordisk's semaglutide fails to slow Alzheimer's progression

The problems with the neurodiversity movement’s language

The problems with the neurodiversity movement’s language

Healthy Start caseworker juggles care and funding uncertainty

Healthy Start caseworker juggles care and funding uncertainty

What closing the 'THC loophole' will mean for patients

What closing the 'THC loophole' will mean for patients